Redondo Beach, CA – November 20, 2003 – Quantimetrix Corporation is pleased to announce that they are certified for a Quality management System according to EN ISO 13485:2000 and are compliant with the regulatory requirements of the European Union (EU) In Vitro Diagnostic Directive (IVDD) and the Canadian Medical Device […]

Redondo Beach, CA – August 7, 2003 – Quantimetrix Corporation is offering a new serum hemoglobin A1c control, GlycoHemosure. The Quantimetrix GlycoHemosure, HbA1c control is intended as a reference material for the monitoring of Serum hemoglobin A1c. Hemoglobin A1c is an important analyte for the long term assessment of glucose […]

Our new real time/on demand laboratory data management program. It’s convenient, accessible, instantaneous, and absolutely free! Learn More…

Redondo Beach, CA – November 19, 2001 – Quantimetrix Corporation is now offering human leukocyte esterase for manufacturing and research use. Human leukocytes are grown in the Quantimetrix tissue culture laboratories, harvested and fixed for subsequent use. Quantimetrix is a Food and Drug (FDA) licensed, ISO-9001 certified facility operating under […]

Redondo Beach, CA – November 19, 2001 – Quantimetrix Corporation is now offering fixed human white blood cells (leukocytes) for manufacturing and research use. Human leukocytes are grown in the Quantimetrix tissue culture laboratories, harvested and fixed for subsequent use. Quantimetrix is a Food and Drug (FDA) licensed, ISO-9001 certified […]

Redondo Beach, CA – November 9, 2001 – The Food & Drug Administration (FDA) has just recently cleared Quantimetrix Corporation’s new Lipoprint System, the only test that measures how much cholesterol is in each LDL (bad) sub-fraction. This new test gives physicians more specific data about a patients LDL sub-fractions […]

Area biotech firm passes FDA test After 10 years of development, Quantimetrix Corp. of Redondo Beach has won approval from the Food and Drug Administration for its cholesterol-measuring device, the company said. The FDA move could be a boon for the private company, which had $8 million in sales last […]